Full Library

Transplant tourism and travel posttransplant, both solid organ and hematopoietic stem cell, are important and distinct topics, and each poses a risk of infection for transplant recipients. As solid organ transplant becomes a more common treatment option for end-stage organ disease, wait lists and wait times for these organs grow. Transplant tourism involves traveling abroad for the purposes of organ transplant and often involves commercial transactions. This process has been discouraged on ethical grounds and is illegal in many countries, however it still occurs. Patients may also travel abroad for stem cell therapies, which include experimental treatments for a growing number of diseases. Physicians managing patients who have received transplants abroad should be aware of the risk of infection in these patients which will be outlined in this chapter. Separate to this, the second part of this chapter addresses the topic of travel in post transplant patients. Solid organ and hematopoietic stem cell transplant recipients may wish to travel as part of their return to regular activities and lifestyle posttransplant. All transplant recipients should seek medical advice prior to travel abroad, and risk of infection will depend on destination(s) and type of travel. Risk reduction strategies are important for these patients to allow for safe travel posttransplant and will be discussed in detail in this chapter.

DOI: 10.1007/978-3-030-01751-4_12-1